Ten Years of HPV Vaccines
نویسندگان
چکیده
Background: Interleukin 17 (IL-17) is a pro-inflammatory cytokine mainly secreted by activated TH-17 cells and involved in inflammatory immune responses. Interleukin 23 (IL-23) sustains the development of inflammation and is considered a check point. Aim: the aim of the present study was to investigate the association between serum IL-17A, IL-17F and serum IL23receptor variants in Saudi women with unexplained spontaneous recurrence of abortion (RSA). Methods: a total of 200 women; 100 RSA-patients matched with 100 controls were enrolled sequentially. Genetic distributions of the two variants of IL-17A, IL-17F and IL-23R genes were detected by a real-time polymerase chain reaction using the Taqman probe method. Results: results showed a significant difference of genetic distribution of IL-17F (7488 T/C) between RSApatients and controls, with respect to homozygous TT (χ2=144, p=0.001), homozygous CC (χ2=113, p=0.001) and heterozygous TC ( χ2=8.87, p=0.003) genotypes that were associated with a significant different frequency of the phenotypic allele T (χ2=65.35, p=0.001) and allele C (χ2=100.90, p=0.005), implying that IL-17F of RSA-group belongs to a different population and/or underwent a mutation in this group of Saudi Arabian women. The adjusted odd ratios were 0.01, 53.08 and 12.24 for TT, TC and CC genotypes, respectively. The odd ratios for the allele T and C were 0.05 and 35.53, respectively. Regarding IL-17A (G-197A) homozygous AA genotype was significantly more frequent in RSA-group (χ2=4.92, p=0.026). For IL-23 (1142 G/A), homozygous GG genes was significantly increased in RSA-patients (χ2=5.364.92, p=0.021). Conclusions: based on these results it can be concluded that genetic variants of IL-17 and IL-23 are involved in the development of RSA in Saudi Arabian women.
منابع مشابه
Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers
Cervical cancer is, globally known to be, one of the most common cancers among women especially indeveloping countries. More than 90% of cervical cancers are associated with high-risk humanpapillomaviruses (HPVs) particularly HPV types 16 and 18. Two major strategies have been developed forprevention and treatment of cervical cancer and other HPV-associated malignancies; the first one is based ...
متن کاملپیشگیری ،HPV ،سرطان سرویکس، واکسیناسیون
Cervical cancer is the second most common gynecologic cancer. A steady 70% annual decline in mortality from cervical cancers has been observed since the mid 20th century after the introduction of widespread papanicolaou cytological screening. But also cervical cancer continues to be an important world health problem for women. Cervical cancer is one of the best- understood neoplasm given its we...
متن کاملAntitumor Response to a Codon-Optimized HPV-16 E7/HSP70 Fusion Antigen DNA Vaccine
Background: Vaccines based on virus-like particles are effective against Human Papilloma Virus (HPV) infection; however, they have not shown a therapeutic effect against HPV-associated diseases. New immunotherapy strategies based on immune responses against tumor antigens can positively affect the clearance of HPV-associated lesions. Objective: To generate two therapeutic fusion DNA vaccines (o...
متن کاملTen years of anti-HPV vaccinations: what do we know?
Human papillomavirus (HPV) is one of the most important carcinogens in humans. Vaccines against HPV are now considered the first anti-cancer vaccinations. Since 2007, in many developed countries, there have been recommendations present for preventive vaccines against HPV. At present, the degree of implementation of these recommendations depends on a number of country-specific factors such as th...
متن کاملUpdate on Safety and Efficacy of HPV Vaccines: Focus on Gardasil
The human papillomavirus (HPV) is a highly contagious and prevalent virus that is primarily sexually transmitted. The Gardasil® quadrivalent vaccine, the Cevarix® bivalent vaccine and the Gardasil® 9 nonavalent vaccine were developed to prevent the spread of HPV as well as the incidence of its associated diseases. The aim of this mini-review is to critically analyze the safety and efficacy of b...
متن کاملProphylactic and therapeutic human papillomavirus vaccine: a breakthrough for women health.
Human Papilloma Virus (HPV) associated cervical cancer is amongst the ten most common cancers in women in the developing world. New vaccines markedly reduce the economic burden of diseases on a country's health system. Two types of HPV vaccines are available; prophylactic and therapeutic. Prophylactic vaccines target (Late protein) L1 and to a lesser extent L2, which stimulate neutralizing anti...
متن کامل